Search research articles
Contact Us
Filters
Showing results (21-30 of 38) with videos related to
Page
of 4
Sort By:
Journal of the American Chemical Society
|
May 4, 2026
A Band-Matching Descriptor Breaks Scaling Relations for Sulfur Electrocatalysts
Xin Jiang, Wenjia Qu, Ruiqing Ye, et al.
Clinical Epigenetics
|
June 24, 2020
Comprehensive evaluation of targeted multiplex bisulphite PCR sequencing for validation of DNA methylation biomarker panels
Dilys Lam, Phuc-Loi Luu, Jenny Z Song, et al.
Clinical and Translational Medicine
|
September 30, 2022
Comprehensive methylome sequencing reveals prognostic epigenetic biomarkers for prostate cancer mortality
Ruth Pidsley, Dilys Lam, Wenjia Qu, et al.
BMC Genomics
|
March 6, 2024
Characterisation and reproducibility of the HumanMethylationEPIC v2.0 BeadChip for DNA methylation profiling
Timothy J Peters, Braydon Meyer, Lauren Ryan, et al.
European Urology
|
November 24, 2018
Serum Free Methylated Glutathione S-transferase 1 DNA Levels, Survival, and Response to Docetaxel in Metastatic, Castration-resistant Prostate Cancer: Post Hoc Analyses of Data from a Phase 3 Trial
Kate L Mahon, Wenjia Qu, Hui-Ming Lin, et al.
Twin Research and Human Genetics : the Official Journal of the International Society for Twin Studies
|
June 4, 2013
GWAS of DNA methylation variation within imprinting control regions suggests parent-of-origin association
Miguel E Rentería, Marcel W Coolen, Aaron L Statham, et al.
Bioinformatics (Oxford, England)
|
August 8, 2018
Evaluation of cross-platform and interlaboratory concordance via consensus modelling of genomic measurements
Timothy J Peters, Hugh J French, Stephen T Bradford, et al.
Nature Communications
|
January 26, 2019
Replication timing and epigenome remodelling are associated with the nature of chromosomal rearrangements in cancer
Qian Du, Saul A Bert, Nicola J Armstrong, et al.
Therapeutic Advances in Medical Oncology
|
April 25, 2022
GUIDE: a randomised non-comparative phase II trial of biomarker-driven intermittent docetaxel <i>versus</i> standard-of-care docetaxel in metastatic castration-resistant prostate cancer (clinical trial protocol)
Ciara Conduit, Blossom Mak, Wenjia Qu, et al.
Epigenetics & Chromatin
|
May 30, 2018
Guidelines for whole genome bisulphite sequencing of intact and FFPET DNA on the Illumina HiSeq X Ten
Shalima S Nair, Phuc-Loi Luu, Wenjia Qu, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 38) with videos related to
Sort By:
Page
of 4
Journal of the American Chemical Society
|
May 4, 2026
A Band-Matching Descriptor Breaks Scaling Relations for Sulfur Electrocatalysts
Xin Jiang, Wenjia Qu, Ruiqing Ye, et al.
Clinical Epigenetics
|
June 24, 2020
Comprehensive evaluation of targeted multiplex bisulphite PCR sequencing for validation of DNA methylation biomarker panels
Dilys Lam, Phuc-Loi Luu, Jenny Z Song, et al.
Clinical and Translational Medicine
|
September 30, 2022
Comprehensive methylome sequencing reveals prognostic epigenetic biomarkers for prostate cancer mortality
Ruth Pidsley, Dilys Lam, Wenjia Qu, et al.
BMC Genomics
|
March 6, 2024
Characterisation and reproducibility of the HumanMethylationEPIC v2.0 BeadChip for DNA methylation profiling
Timothy J Peters, Braydon Meyer, Lauren Ryan, et al.
European Urology
|
November 24, 2018
Serum Free Methylated Glutathione S-transferase 1 DNA Levels, Survival, and Response to Docetaxel in Metastatic, Castration-resistant Prostate Cancer: Post Hoc Analyses of Data from a Phase 3 Trial
Kate L Mahon, Wenjia Qu, Hui-Ming Lin, et al.
Twin Research and Human Genetics : the Official Journal of the International Society for Twin Studies
|
June 4, 2013
GWAS of DNA methylation variation within imprinting control regions suggests parent-of-origin association
Miguel E Rentería, Marcel W Coolen, Aaron L Statham, et al.
Bioinformatics (Oxford, England)
|
August 8, 2018
Evaluation of cross-platform and interlaboratory concordance via consensus modelling of genomic measurements
Timothy J Peters, Hugh J French, Stephen T Bradford, et al.
Nature Communications
|
January 26, 2019
Replication timing and epigenome remodelling are associated with the nature of chromosomal rearrangements in cancer
Qian Du, Saul A Bert, Nicola J Armstrong, et al.
Therapeutic Advances in Medical Oncology
|
April 25, 2022
GUIDE: a randomised non-comparative phase II trial of biomarker-driven intermittent docetaxel <i>versus</i> standard-of-care docetaxel in metastatic castration-resistant prostate cancer (clinical trial protocol)
Ciara Conduit, Blossom Mak, Wenjia Qu, et al.
Epigenetics & Chromatin
|
May 30, 2018
Guidelines for whole genome bisulphite sequencing of intact and FFPET DNA on the Illumina HiSeq X Ten
Shalima S Nair, Phuc-Loi Luu, Wenjia Qu, et al.
Page
of 4